[1]王磊.泽泻饮合京三棱丸治疗非酒精性脂肪肝34例[J].西部中医药,2013,26(09):64-65.
　WANG Lei.ZeXie Drink and Jing SanLengWan in Treating 34 Cases of Non Alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(09):64-65.
点击复制

泽泻饮合京三棱丸治疗非酒精性脂肪肝34例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年09期
页码:
64-65
栏目:
出版日期:
2013-09-15

文章信息/Info

Title:
ZeXie Drink and Jing SanLengWan in Treating 34 Cases of Non Alcoholic Fatty Liver Disease
文章编号:
1004-6852(2013)09-0064-02
作者:
王磊
庆阳市人民医院肿瘤外科，甘肃 庆阳 745000
Author(s):
WANG Lei
Surgical Department of Oncology in Qingyang Municipality People′s Hospital, Qingyang 745000, China
关键词:
脂肪肝; 非酒精性; 泽泻饮; 京三棱丸
Keywords:
non alcoholic fatty liver disease;  ZeXie drink;  Jing SanLengWan
分类号:
R575.5
文献标志码:
B
摘要:
目的：观察泽泻饮合京三棱丸治疗非酒精性脂肪肝的临床疗效。方法：将68例脂肪肝患者随机分为治疗组、对照组各34例。2组均调整饮食及合理运动，同时给予水飞蓟宾300 mg/次，3次/d。治疗组同时服用泽泻饮合京三棱丸加味，水煎分服，1剂/d。2组均以治疗1个月为1个疗程，治疗1个疗程后观察疗效。结果：显效率对照组为35.29%，治疗组为58.82%，2组相比差异显著（P＜0.05）；总有效率对照组为64.71%，治疗组为82.35%，2组相比差异显著（P＜0.05）。高密度脂蛋白胆固醇(HDL-C)、血清胆固醇(TC)、甘油三酯(TG)等指标治疗后均明显改善（P＜0.05），治疗组改善较对照组明显（P＜0.05）。结论：泽泻饮合京三棱丸治疗脂肪肝临床疗效显著，能有效改善血脂水平。
Abstract:
Objective: To explore clinical effects of ZeXie drink and Jing SanLengWan in the treatment for non alcoholic fatty liver disease. Method: All 68 patients were randomized into the treatment group and the control group. Both groups accepted dietary regulation, proper exercise and ShuiFei JiBin, 300 mg each time, three times per day. The treatment group took modified ZeXie drink and Jing SanLengWan, water decocted, one dose per day. One month were one course of treatment, to observe clinical effects after one course of treatment. Result: Effectual rate of the control group was 35.29%, lower than 58.82% of the treatment group with significant difference (P＜0.05); Total effective rates of both groups were 64.71% and 82.35%, the difference between both groups was significant (P＜0.05). HDL-C, TC, TG and other indexes were improved after treating (P＜0.05), the treatment group was improved more significantly than the control group (P＜0.05). Conclusion: Modified ZeXie drink and Jing SanLengWan are effective in treating fatty liver disease and improve the levels of blood lipid.

相似文献/References:

[1]崔兰玲.对脂肪肝中医病因病机的认识[J].西部中医药,2013,26(06):20.
　CUI Lanling.The Understanding of Etiology and Pathogenesis of Fatty Liver[J].Western Journal of Traditional Chinese Medicine,2013,26(09):20.
[2]胡利勋,卢红元.运动介入疗法治疗肥胖型大学生脂肪肝64例临床观察*[J].西部中医药,2014,27(05):93.
　HU Lixun,LU Hongyuan.Clinical Observation on Treating 64 Cases of Fatty Liver of Obese Undergraduates by Exercise Intervention Therapy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):93.
[3]陈芳玉,张杰,毛莲香,等.疏肝健脾化痰汤治疗非酒精性脂肪性肝炎50例[J].西部中医药,2015,28(06):94.[doi:2015/6/16 0:00:00]
[4]赵 明,卢红元,杨建全.运动疗法治疗脂肪肝92例*[J].西部中医药,2014,27(01):99.
　ZHAO Ming,LU Hongyuan,YANG Jianquan.Exercise Therapy in Treating 92 Cases of Fatty Liver[J].Western Journal of Traditional Chinese Medicine,2014,27(09):99.
[5]江明洁,贺劲松△.“三因制宜”理论辨治非酒精性脂肪性肝病[J].西部中医药,2018,31(10):22.
　JIANG Mingjie,HE Jinsong.Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”[J].Western Journal of Traditional Chinese Medicine,2018,31(09):22.
[6]陶庆,蓝健姿,曹建红,等.东方肝康口服液治疗非酒精性脂肪性肝病疗效观察[J].西部中医药,2019,32(07):1.
　TAO Qing,LAN Jianzi,CAO Jianhong,et al.Clinical Observation on DongFang GanKang Oral Liquid in the Treatment for Nonalcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2019,32(09):1.
[7]蒋云霞,罗伟生.荔枝核治疗肝脏疾病研究进展[J].西部中医药,2021,34(05):144.[doi:10.12174/j.issn.2096-9600.2021.05.37]
　JIANG Yunxia,LUO Weisheng.Research Progress of Litchi Seed in the Treatment of Hepatic Diseases[J].Western Journal of Traditional Chinese Medicine,2021,34(09):144.[doi:10.12174/j.issn.2096-9600.2021.05.37]
[8]姜慧,李军祥,谭祥,等.基于网络药理学和分子对接探讨健脾疏肝方治疗非酒精性脂肪性肝病的作用机制[J].西部中医药,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]
　JIANG Hui,LI Junxiang,TAN Xiang,et al.The Mechanism of Invigorating-spleen Soothing-liver Prescription in the Treatment of Non-alcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(09):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]
[9]王晋阳,杨少军△,井小会.中医药化浊降脂法治疗非酒精性脂肪肝的研究进展*[J].西部中医药,2015,28(02):132.
[10]张玉香,王一强,姜德民,等.清肝祛湿活血方对非酒精性脂肪肝大鼠肿瘤坏死因子α及肝脏组织的影响[J].西部中医药,2018,31(08):13.
　ZHANG Yuxiang,WANG Yiqiang,JIANG Demin,et al.Effects of Liver-clearing Dampness-removing Blood Circulation-promoting Prescription on Liver Tissue and TNF-α of the Rats with Non-alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(09):13.

备注/Memo

备注/Memo:
收稿日期：2013-04-25 作者简介：王磊(1973—)，男，主治医师。研究方向：外科常见病的中西医诊治。
更新日期/Last Update: 2013-09-15